FDA approves CartiHeal's Implant for the Treatment of Cartilag...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
KFAR SABA, Israel, March 30, 2022 /PRNewswire-AsiaNet/ -- CartiHeal Ltd, developer of implants for the treatment of cartilage and osteochondral defects in arthritic and non-arthritic knee-joints, today announced that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for its...
Authors: LATEST ASIANET NEWS RELEASES